Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 22, 2022 - Issue 4
Submit an article Journal homepage
1,712
Views
0
CrossRef citations to date
0
Altmetric
Special report

What might have happened: the impact of interrupting entry of innovative drugs on disease outcomes in the United States

William Herringa RTI Health Solutions, NC, USAView further author information
,
Michael Ciarametarob National Pharmaceutical Council, Washington, DC, USAView further author information
,
Josephine Mauskopfa RTI Health Solutions, NC, USACorrespondence[email protected]
View further author information
,
David Wamblea RTI Health Solutions, NC, USAView further author information
,
Brian Silsb National Pharmaceutical Council, Washington, DC, USAView further author information
&
Robert Duboisb National Pharmaceutical Council, Washington, DC, USAView further author information
Pages 529-541 | Received 04 Oct 2021, Accepted 25 Jan 2022, Published online: 21 Feb 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.